A Randomized Multicenter Study for Isolated Skin Vasculitis
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Multi-center sequential multiple assignment randomized trial comparing the effectiveness of
three different standard of care treatment options for patients with isolated skin
vasculitis.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
National Center for Advancing Translational Science (NCATS) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Office of Rare Diseases (ORD)